Ropivacaine Hydrochloride Injection, Solution
NDC Package 68462-795-55
Package Information
Ropivacaine Hydrochloride injection is indicated for the production of local or regional anesthesia for surgery and for acute pain management.Surgical Anesthesia: epidural block for surgery including cesarean section; major nerve block; local infiltration. This formulation utilizes a injection, solution delivery system. Marketed by Glenmark Pharmaceuticals Inc., Usa, this product is identified by NDC 68462-795 and is authorized under FDA application ANDA219883.
Identification & Billing
- RxCUI: 1734084 - ROPivacaine HCl 1 % in 20 ML Injection
- RxCUI: 1734084 - 20 ML ropivacaine hydrochloride 10 MG/ML Injection
- RxCUI: 1734084 - ropivacaine HCl 1 % per 20 ML Injection
- RxCUI: 1734084 - ropivacaine HCl 200 MG per 20 ML Injection
- RxCUI: 1734203 - ROPivacaine HCl 0.2 % in 10 ML Injection
Clinical Specifications
- Epidural - Administration upon or over the dura mater.
- Infiltration - Administration that results in substances passing into tissue spaces or into cells.
- Perineural - Administration surrounding a nerve or nerves.
Regulatory & Marketing
Hierarchy Structure
- 68462 - Glenmark Pharmaceuticals Inc., Usa
- 68462-795 - Ropivacaine Hydrochloride
- 68462-795-55 - 25 VIAL in 1 CARTON / 20 mL in 1 VIAL (68462-795-20)
- 68462-795 - Ropivacaine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68462-795-55 identifies a specific commercial package of 25 vial in 1 carton / 20 ml in 1 vial (68462-795-20) of Ropivacaine Hydrochloride, a human prescription drug labeled by Glenmark Pharmaceuticals Inc., Usa. This injection, solution is formulated for epidural; infiltration; perineural use and contains ropivacaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Glenmark Pharmaceuticals Inc., Usa on August 07, 2025. The current certification is valid through December 31, 2027.
How is this Glenmark Pharmaceuticals Inc., Usa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68462079555. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.